本页面由Tiger Trade Technology Pte. Ltd.提供服务

ENDRA Life Sciences Inc

5.14
-0.3250-5.95%
成交量:1.58万
成交额:8.39万
市值:770.15万
市盈率:-0.82
高:5.65
开:5.65
低:5.05
收:5.46
52周最高:8.00
52周最低:2.96
股本:149.98万
流通股本:136.22万
量比:0.90
换手率:1.16%
股息:- -
股息率:- -
每股收益(TTM):-6.2900
每股收益(LYR):-8.9291
净资产收益率:-152.04%
总资产收益率:-77.32%
市净率:1.22
市盈率(LYR):-0.58

数据加载中...

2025/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/25

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/07/23

重要事件披露

Form 8-K - Current report
2025/07/16

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/07/09

重要事件披露

Form 8-K - Current report
2025/07/09

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2025/06/11

重要事件披露

Form 8-K - Current report
2025/05/30

重要事件披露

Form 8-K - Current report
2025/05/15

重要事件披露

Form 8-K - Current report
2025/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/05

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2025/04/03

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/31

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/31

重要事件披露

Form 8-K - Current report
2024/11/22

重要事件披露

Form 8-K - Current report
2024/11/21

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/11/19

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/15

重要事件披露

Form 8-K - Current report
2024/11/05

重要事件披露

Form 8-K - Current report
2024/10/30

重要事件披露

Form 8-K - Current report